Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvin L Billingsley

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmacology|September 20, 2008
Druggable targets and targeted drugs: enhancing the development of new therapeuticsMelvin L Billingsley
Pharmacology|July 25, 2013
The field of pharmacologyMelvin L Billingsley
Brain Research|June 24, 2004
Domoic acid enhances Bcl-2-calcineurin-inositol-1,4,5-trisphosphate receptor interactions and delayed neuronal death in rat brain slicesNuray Erin, Melvin L Billingsley
Nature Biotechnology|December 13, 2006
Maximizing state and federal spending while minimizing conflictsMelvin L Billingsley, Michele Washko
The Journal of Pharmacology and Experimental Therapeutics|March 31, 2005
Protein kinase C epsilon regulates tumor necrosis factor-alpha-induced stannin gene expressionBrian E Reese, Collin Davidson, Melvin L Billingsley, et al.
Gene Expression|April 1, 2006
Elucidation of stannin function using microarray analysis: implications for cell cycle controlBrian E Reese, Dan Krissinger, Jong K Yun, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 28, 2002
Abnormal cerebellar signaling induces dystonia in miceCarolyn E Pizoli, H A Jinnah, Melvin L Billingsley, et al.
Brain Research. Molecular Brain Research|June 1, 2005
The protein stannin binds 14-3-3zeta and modulates mitogen-activated protein kinase signalingCollin E Davidson, Brian E Reese, Melvin L Billingsley, et al.
Molecular Pharmacology|July 23, 2004
Stannin, a protein that localizes to the mitochondria and sensitizes NIH-3T3 cells to trimethyltin and dimethyltin toxicityCollin E Davidson, Brian E Reese, Melvin L Billingsley, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacology|September 20, 2008
Druggable targets and targeted drugs: enhancing the development of new therapeuticsMelvin L Billingsley
Pharmacology|July 25, 2013
The field of pharmacologyMelvin L Billingsley
Brain Research|June 24, 2004
Domoic acid enhances Bcl-2-calcineurin-inositol-1,4,5-trisphosphate receptor interactions and delayed neuronal death in rat brain slicesNuray Erin, Melvin L Billingsley
Nature Biotechnology|December 13, 2006
Maximizing state and federal spending while minimizing conflictsMelvin L Billingsley, Michele Washko
The Journal of Pharmacology and Experimental Therapeutics|March 31, 2005
Protein kinase C epsilon regulates tumor necrosis factor-alpha-induced stannin gene expressionBrian E Reese, Collin Davidson, Melvin L Billingsley, et al.
Gene Expression|April 1, 2006
Elucidation of stannin function using microarray analysis: implications for cell cycle controlBrian E Reese, Dan Krissinger, Jong K Yun, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 28, 2002
Abnormal cerebellar signaling induces dystonia in miceCarolyn E Pizoli, H A Jinnah, Melvin L Billingsley, et al.
Brain Research. Molecular Brain Research|June 1, 2005
The protein stannin binds 14-3-3zeta and modulates mitogen-activated protein kinase signalingCollin E Davidson, Brian E Reese, Melvin L Billingsley, et al.
Molecular Pharmacology|July 23, 2004
Stannin, a protein that localizes to the mitochondria and sensitizes NIH-3T3 cells to trimethyltin and dimethyltin toxicityCollin E Davidson, Brian E Reese, Melvin L Billingsley, et al.
Pageof 1